These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21414717)

  • 1. Sirtuin 1 in malignant transformation: friend or foe?
    Fang Y; Nicholl MB
    Cancer Lett; 2011 Jul; 306(1):10-4. PubMed ID: 21414717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1: tumor promoter or tumor suppressor?
    Lim CS
    Med Hypotheses; 2006; 67(2):341-4. PubMed ID: 16546327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of the class III histone deacetylase SIRT1 in cancer.
    Liu T; Liu PY; Marshall GM
    Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
    Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
    Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
    Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 1 (SIRT1): the misunderstood HDAC.
    Stünkel W; Campbell RM
    J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 is significantly elevated in mouse and human prostate cancer.
    Huffman DM; Grizzle WE; Bamman MM; Kim JS; Eltoum IA; Elgavish A; Nagy TR
    Cancer Res; 2007 Jul; 67(14):6612-8. PubMed ID: 17638871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPalpha regulates SIRT1 expression during adipogenesis.
    Jin Q; Zhang F; Yan T; Liu Z; Wang C; Ge X; Zhai Q
    Cell Res; 2010 Apr; 20(4):470-9. PubMed ID: 20157332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology.
    Robers MB; Loh C; Carlson CB; Yang H; Frey EA; Hermanson SB; Bi K
    Mol Biosyst; 2011 Jan; 7(1):59-66. PubMed ID: 20931131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the SIRT1 protein deacetylase in cancer.
    Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
    Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
    Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.
    Lim JH; Lee YM; Chun YS; Chen J; Kim JE; Park JW
    Mol Cell; 2010 Jun; 38(6):864-78. PubMed ID: 20620956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
    Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
    Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The skinny on SIRT1 regulation.
    Schug TT
    Dis Model Mech; 2010; 3(9-10):507-8. PubMed ID: 20483999
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered methylation in gene-specific and GC-rich regions of DNA is progressive and nonrandom during promotion of skin tumorigenesis.
    Bachman AN; Curtin GM; Doolittle DJ; Goodman JI
    Toxicol Sci; 2006 Jun; 91(2):406-18. PubMed ID: 16569730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.